AzTrials
AzTrials

AnesthesiaNCT04105660

Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)

A study testing Training for EEG monitoring and Standard monitoring in people with Anesthesia, run by University Hospital, Basel, Switzerland at 4 sites in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anesthesia
What is being tested?
Training for EEG monitoring and Standard monitoring
Could I receive a placebo?
No, everyone receives an active treatment
How many people
232 participants
Where
4 sitesSwitzerland
Study dates
1 Jul 2021to 30 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients undergoing in-hospital laparoscopic abdominal surgery with general anaesthesia using Propofol based on the Schnider model (target controlled infusion)42, 43
  • Minimal duration of surgery of 60 minutes
  • Written informed consent

Who cannot join

  • Same-day surgery
  • Language barrier
  • Patients under 18 years of age
  • Pregnancy (using a beta-human chorionic gonadotropin (HCG) measurement in a blood sample of women in childbearing age)
  • Allergy to Propofol
  • Administration of hypnotics other than Propofol, such as ketamine or midazolam preoperatively or intraoperatively
  • Known brain pathology, such as seizure disorders, dementia, cerebrovascular disease or brain death

Trial locations and contacts

4 sites in 1 country.

Switzerland4 sites
  • Cantonal Hospital Aarau

    Aarau

  • University Hospital Basel

    Basel

  • Cantonal Hospital Graubünden

    Chur

  • Clinic of Anaesthesiology

    Geneva

Other trials in Switzerland

About this study

Official title: Recovery From Propofol Anaesthesia Guided by Frontal EEG Wave Analysis Compared to Bispectral Index Monitoring Alone in Laparoscopic Surgery: A Multicentre Double-blind Randomised Controlled Trial

Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia.

Read the detailed description

Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia. In addition to the bispectral (BIS) index displayed as an index, the raw frontal EEG can be displayed as a curve on these monitors. After a short training, anaesthetists might be more accurate and faster in assessing depth of anaesthesia by recognizing the pattern of the EEG curve than by using the BIS index. This may further enhance the positive effects that could be demonstrated for the use of BIS monitors.

Therefore, the aim of the investigator's study is to investigate the clinical relevance of interpreting the raw frontal EEG in addition to only using the BIS index for titrating intravenous anaesthetics.

Conditions
Anesthesia
Being tested
Training for EEG monitoring, Standard monitoring

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training for EEG monitoringOther

    Training for reading EEG curves during anaesthesia

  • Standard monitoringOther

    Standard monitoring including clinical parameters and BIS index

Study groups in NCT04105660
Study groupRoleWhat they receive
Intervention armExperimentalEEG monitoring in addition to standard monitoring (clinical parameters and BIS index)
Receives: Other: Training for EEG monitoring; Other: Standard monitoring
Control armActive comparatorStandard monitoring including clinical parameters and BIS index
Receives: Other: Standard monitoring

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quality of recovery (QoR): QoR-15 scale

    QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)

    Measured: 24 hours after surgery

Secondary outcomes (7)
  1. Propofol consumption

    Propofol consumption in mg/kg/h

    Measured: during anaesthesia

  2. Quality of recovery (QoR): QoR-15 scale

    QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)

    Measured: 48 hours after surgery

  3. Time spent in postanaesthesia care unit (PACU)

    Time in minutes from arrival in PACU until discharge from PACU

    Measured: At arrival to and at discharge from postanaesthesia care unit (an average of 120 minutes)

  4. Time to extubation

    Time in minutes from skin closure to extubation

    Measured: At time of skin closure and at time of extubation (an average of 90 minutes)

  5. Risk of awareness

    Brice interview daily until hospital discharge

    Measured: daily from admission up to hospital discharge, an average of approximately 14 days

  6. Aldrete score

    Measurement of recovery; score is 0 to 10, 0 means worst recovery, 10 means best recovery

    Measured: Once at discharge from postanaesthesia care unit (PACU), approximately on day 2 of admission to hospital

  7. Incidence of Postoperative Nausea and Vomiting (PONV)

    Incidence of nausea and vomiting daily until hospital discharge

    Measured: daily from admission up to hospital discharge, an average of approximately 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Sep 2019
  2. Study start1 Jul 2021
  3. Primary completion28 May 2022
  4. Study completion30 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
232 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04105660
Sponsor's protocol ID
2019-00132
Other IDs
2019
Status last verified
Apr 2023
First submitted
17 Sep 2019
Last updated
18 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified participant data will be available upon reasonable request from the last authors of this publication (Christoph S. Burkhart, ORCID 0000-0002-9288-117X and Salome Dell-Kuster, ORCID 0000-0001-7219-7138)

Publications

  • Gruber BU, Girsberger V, Kusstatscher L, Funk S, Luethy A, Jakus L, Maillard J, Steiner LA, Dell-Kuster S, Burkhart CS. Comparing propofol anaesthesia guided by Bispectral Index monitoring and frontal EEG wave analysis with standard monitoring in laparoscopic surgery: protocol for the 'EEG in General Anaesthesia - More Than Only a Bispectral Index' Trial, a multicentre, double-blind, randomised controlled trial. BMJ Open. 2022 Jun 10;12(6):e059919. doi: 10.1136/bmjopen-2021-059919.

    PubMed 35688587

Questions about this trial

What is this clinical trial studying?

A study testing Training for EEG monitoring and Standard monitoring in people with Anesthesia, run by University Hospital, Basel, Switzerland at 4 sites in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quality of recovery (QoR): QoR-15 scale (time frame: 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04105660, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in